Nurix Therapeutics Inc. (NRIX)
NASDAQ · Healthcare
Nurix Therapeutics Inc. Operating Income 2019–2025
Nurix Therapeutics Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Nurix Therapeutics Inc. operating income for the quarter ending February 28, 2026 was -92.5 M, a 47.14% increase year-over-year.
- Nurix Therapeutics Inc. operating income for the twelve months ending February 28, 2026 was -295.1 M, a 56.63% increase year-over-year.
- Nurix Therapeutics Inc. annual operating income for 2025 was -285.7 M, a 34.10% increase from 2024.
- Nurix Therapeutics Inc. annual operating income for 2024 was -213.0 M, a 37.38% increase from 2023.
- Nurix Therapeutics Inc. annual operating income for 2023 was -155.1 M, a 15.67% decrease from 2022.
- Nurix Therapeutics Inc. annual operating income for 2022 was -183.9 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Nurix Therapeutics Inc. Operating Income — FAQ
Nurix Therapeutics Inc. (NRIX) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Nurix Therapeutics Inc.'s operating income?
Nurix Therapeutics Inc. (NRIX) reported operating income of -$286M for fiscal 2025.
Where can I see NRIX's operating income history?
The chart and table above show Nurix Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.